BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cells » iPS Cells » Page 51

3 Bullet Thursday – Stem Cells for HIV, ESCs vs. iPSCs, and Twitter as a News Source

By Leave a Comment

Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.

 

1. Wow, the world’s first clinical trial to treat HIV patients using umbilical cord blood transplants is set to start in Spain. Plans for the trial were announced last week at a haematology conference in Valencia by Spain’s National Organisation of Transplants (ONT).

 

2. Talk about a controversial topic! A new study published in Nature Biotechnology announces embryonic stem cells and induced pluripotent stem cells to be “equal.” More specifically, the authors state, “We conclude that hESCs and hiPSCs are molecularly and functionally equivalent.”

 

3. In a July 2013 USA Today article, Rem Rieder discusses how Twitter is a news pipeline for more than 200 million active users, often ‘breaking’ news before it’s actually news. Want to know where to get your morning stem cell news? These are the top 15 accounts breaking stem cell news on Twitter.

 

Happy Thursday!

 

Want to get this fun weekly update?  Join below and we’ll keep you in the loop, starting next week.

3 Bullet Thursday – Stem Cells for Bioprinting, Fertility, & Replacement Organs (Oct 22, 2015)

By Leave a Comment

Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.

1. RoosterBio has released the world’s first ever ready-to-print (RTP) stem cell product, “thaw and use” human mesenchymal stem cells (hMSCs). This advance will make standardized cells accessible for rapid 3D bioprinting and tissue engineering. Totally incredible.

2. Scientists from Egypt’s Mansoura Medical School have successfully reversed infertility from cancer by directly injecting stem cells into the ovaries.

3. Will we eventually grow replacements organs using our own stem cells? It’s possible, as two research teams released news of growing kidney structures from stem cells within the past month.

First, an American team lead by Dr. Ryuji Morizane published findings in Nature Biotechnology that they had converted induced pluripotent stem cells (iPSCs) into kidney structures that resemble those from a normal human kidney.

Second, a team of Australian researchers lead by Dr. Minoru Takasato successfully grew nephron organoids from iPSCs, releasing their results in Nature.

It’s been quite a week. Happy Thursday!

Want to get this fun weekly update?  Join below and we’ll keep you in the loop, starting next week!

Guest Post: Role of the Physio-chemical Environment in Steering Stem Cell Differentiation

By Leave a Comment

This guest post by JM Wilkinson and Kelly S. Davidge of Kirkstall Ltd. highlights an emerging technology, organotypic cell cultures.  

Cell culture has come a long way in the last 20 years. 3D is rapidly replacing 2D (plated cells on cover slips) and now perfusion based systems with gentle flow of media are improving proliferation rates, control of differentiation and cell function. For in vitro safety and efficacy testing the goal is organotypic behaviour where the cell metabolism accurately reflects what happens in the human body. However some of the techniques also have direct relevance for stem cell research too. In this note we discuss some of the important factors that help to steer stem cell differentiation and could deliver mature cells with low batch to batch variation and a far more homogeneous population. [Read more…]

Top 10 Most Shared Stem Cell Articles of the Past 12 Months

By Leave a Comment

Social Analytics Reveal Key Findings about Stem Cell Article Popularity

The field of stem cell research has boomed over the past twelve months, bringing to light new ideas for treatments and applications. Here at BioInformant, we strive to do our best to provide you with the most up to date information related to the industry. As a supplement to our monthly round-ups, we thought it would be important to share the top ten most shared stem cell articles from the past year.
[Read more…]

Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics Honored as iPSC Industry Influencer by BioInformant

By Leave a Comment

Recently, BioInformant released an article titled,  “Do You Know the Top 5 iPS Cell Influencers (Right Now)?” In it, we named the five most important thought leaders that are driving therapeutic and commercial progress with induced pluripotent stem cells (iPS cells) right now in 2015. One of the important individuals that we highlighted was Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics.

In response to this article, Ocata Therapeutics released a press release announcing that “Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics has been awarded the honor of iPSC industry influencer by BioInformant, a leading research firm serving the stem cell sector.” [Read more…]

BioInformant's World-Class Clients